Fundz

Elucida Oncology, Inc. reported raising $17.7 Million in an initial SEC Form D filing, from an offering of $35 Million

PRIVATENov 10, 2020

Amount Raised

$17.7 Million

$17.7 Million sold, per SEC Form D (first sale Nov 10, 2020)

Round Type

Venture

Monmouth JunctionBiotechnology

Who to call at Elucida Oncology, and when

A new round usually means Elucida Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elucida Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elucida Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elucida Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elucida Oncology

Location

Monmouth Junction, New Jersey, United States

About

Elucida Oncology, Inc., is a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy with its first-in-class, ultra-small nanoparticle C’Dot drug conjugate (CDC) platform. CDCs are designed to penetrate deeper into tumors and deliver a significantly higher payload compared to antibody drug conjugates (ADCs). This combined with greater avidity for the target antigen, longer retention in tumors with minimal systemic exposure due to rapid renal clearance confers unique Target or Clear® properties. In preclinical studies, this has resulted in enhanced efficacy irrespective of antigen expression levels with reduced off-target toxicity, thereby potentially addressing the limitations of ADCs and other novel drug carriers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elucida Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts90 people are listed at Elucida Oncology. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elucida Oncology's next move

See what Strategic adds

Elucida Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.